Gustavo Pradilla

We have enrolled our 1st patient into the REACH clinical trial led by @gpradil2 Dr. Gustavo Pradilla. This is the 1st study to investigate the use of minimally invasive parafascicular surgery for deep ICH, particularly within anterior basal ganglia. #neurosurgery #REACH

#ONSNew Biportal Endoscopic TransOrbital and transMaxillary Approach to the Cranio-Orbital Region and Middle Cranial Fossa: A Preliminary Analysis of Maneuverability bit.ly/4aIb2CY by @Leonard_T_MD et al @EmoryMedicine @MdOlabisi @CNS_Update

Save the date (and your spot) for the Emory 2025 skull base anatomy course. 🧠 see you there. @gpradil2 @GarzonMuvdi @EmoryNeurosurg @EmorySkullBase @EmoryUniversity

The Marcus Foundation makes major $25.9 million award to advance lifesaving stroke research at Emory and Grady news.emory.edu/stories/2024/0…

Through the ENRICH Trial @EmoryNeurosurg gives hope to patients suffering from hemorrhagic stroke. Our surgeons combine forces with @NICONeuroCorp & @SynaptiveMed for a promising surgical treatment on this week’s episode of @YrFantasticMind. See you on 5/15 at 7pm on @mygpb.

instagram.com/reel/C6-KT24tl…

Groundbreaking results from a 6-year clinical trial investigating treatment for hemorrhagic strokes, led by @EmoryNeurosurg, show the minimally invasive approach under study is safe and superior to the current standard of care. news.emory.edu/stories/2024/0…

@NeurosurgeryUSC was thrilled to be an initial site for the #ENRICH trial just published in @NEJM. Congrats to my friend Gustavo Pradilla and @EmoryNeurosurg! #Neurosurgery #Stroke

In the ENRICH trial of minimally invasive cerebral hematoma removal within 24 hours after onset of hemorrhage, functional outcomes were better with surgery than with medical treatment, particularly among patients with lobar hemorrhages. Full trial results: nej.md/3VPYggf

Editorial: New Hope for Adults with Lobar Intracerebral Hemorrhage nej.md/49uI0ob

Major RCT: ENRICH minimally invasive cerebral hematoma remova 24 hours after onset, functional outcomes better w surgery than medical treatment, particularly among patients with lobar hemorrhages. Great work @gpradil2 & co. Thanks for including us: nej.md/3VPYggf

Congrats to ⁦@gpradil2⁩ and all #ENRICH investigators. Big day in #neurosurgery with ⁦@emoryhealthcare⁩ ⁦⁦@EmoryNeurosurg⁩ leading the way! ⁦@NEJM⁩ ⁦@CNS_Update⁩ ⁦@cvsection⁩ ⁦@AANSNeuro⁩ ⁦@SNISinfo⁩ nejm.org/doi/full/10.10…

Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage @NEJM nejm.org/doi/full/10.10…. Congratulations to the @EmoryMedicine investigators that designed and led this important trial @EmoryatGrady @emoryhealthsci

Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage | New England Journal of Medicine nejm.org/doi/full/10.10…

So saddened to learn today that #neurosurgery lost (1 week ago) one of its pioneers in #skullbase & #cerebrovascular surgery, #TakanoriFukushima. He was the consummate innovative naturally skilled neurosurgical artist who exuded passion, perfected his craft & inspired legions😥

Congrats to our @EmoryNeurosurg 2024 incoming class. We are excited to have you join us.

"No one can whistle a symphony. It takes a whole orchestra to play it." @EmorySkullBase 2023 course is ended. Great experience and exceptional teamwork. @alerodas23 @edoardoporto @ErionJr @ManuRevuelta @yzohdy95 @gpradil2 @GarzonMuvdi

Skull Base Course 2023 wrap-up! Kudos to the incredible speakers, participants, and organizing team for making this a transformative learning experience! ✅ @gpradil2 @GarzonMuvdi @edoardoporto @alerodas23 @ManuRevuelta @Leonard_T_MD @bkpatel1389

Get your abstracts in ! This will be a memorable meeting !